SCHEMBL9163377

SCHEMBL9163377

[CH2]C(O)CCBr

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10619825 0.76
SCHEMBL891681 0.72
SCHEMBL622595 0.69 TRPV1 (0.32)
SCHEMBL2198883 0.69
SCHEMBL7138282 0.69
SCHEMBL3332382 0.69 ALDH1A1 (0.41)
SCHEMBL11037372 0.67
SCHEMBL94448 0.67
SCHEMBL7040037 0.67
SCHEMBL9318011 0.67

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-103788098-A Azetidine and cyclobutane derivatives as JAK inhibitors INCYTE CORP 2014-05-14 CN disclosed
CN-103717586-A Benzodioxepine and benzodioxine compounds that interact with glucokinase regulatory protein for the treatment of diabetes AMGEN INC 2014-04-09 CN disclosed
CN-102026999-B Azetidine and cyclobutane derivatives as JAK inhibitors INCYTE CORP 2014-03-05 CN disclosed
CN-1030768-C Primidine derivatives, process for preparing same and inhibitor for androgen OTSUKA PHARMA CO LTD (JP) 1996-01-24 CN disclosed
US-5420128-A Pyrimidine derivatives, method of manufacturing the same, and androgen inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1995-05-30 US disclosed
EP-0503099-A1 PYRIMIDINE DERIVATIVE, PRODUCTION THEREOF, AND ANDROGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-09-16 EP disclosed
CN-1060844-A Pyrimidine derivatives, its method for making and inhibitor for androgen OTSUKA PHARMA CO LTD (JP) 1992-05-06 CN disclosed